Skip to main content
. 2013 Jan 21;19(3):375–380. doi: 10.3748/wjg.v19.i3.375

Table 2.

Summary of patients with concomitant cholangiocarcinoma

Case Age/sex Stone location Procedure Residual/recurrent stones Margin pTNM Interval from CCA to death (mo)
89 50/F R S5/6/7 -/- Free T1 N1 M0 3
90 68/F L LH -/- Free T1 Nx M0 Alive (140)
119 82/F L LL -/- Atypical mucinous epithelium T1 Nx M0 73
128 60/M L LH -/- Free T1 N0 M0 3 (hypopharyngeal tumor)
142 39/F L LL -/- Free T4 N1 M0 3
212 76/F L S2 -/- Inadequate T1 Nx M0 56
227 61/F L LH + RA -/+ Free T1 N0 M0 107 (re-operated 4 years later due to CCA recurrence at CBD)
253 72/F L LH -/- Free T1 N0 M0 Alive (49)
143 50/F BI LH + S5 -/+ Free T1 Nx M0 Alive (119) (re-operated 5 years later due to CCA recurrence at CBD)
217 56/F BI RH +/- Inadequate T2a Nx M0 5

L: Left; R: Right; BI: Bilateral; LH: Left hemihepatectomy; LL: Left lateral sectionectomy; RH: Right hemihepatectomy; RA: Right anterior sectionectomy; S5: Segment 5; S2: Segment 2; CCA: Cholangiocarcinoma; CBD: Common bile duct; pTNM: Pathologic TNM stage for intrahepatic bile duct according to AJCC 7th edition; F: Female; M: Male.